14.05 USD
▼+0.13-0.35%
盘后 14.03 -0.50%
2026-08-03
市值
$191.38M
市盈率
—
EPS
-5.07
股息率
—
52 周区间
5.06 – 15.84
成交量
249.71K
Beta
1.40
目标价
41.90
52W 低 5.0652W 高 15.84
价格走势
公司简介
Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical and phase 2 clinical development for patients with relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis. The company also develops IMU-856, which is entering Phase 2 clinical trial, for the restoration of the intestinal barrier function in patien...